Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani(Unknown), Kate Adams, Mahmoud Abouibrahim, Charlotte Adams, Sadia Abbasi, Amaka Achara, Ahmed Abou-Haggar, Abraheem Abraheem, Janet Acheson(University of Dundee), Althaf Abdul Rasheed, Jacqueline Adabie-Ankrah, Yazeed Abed El Khaleq, Judith Abrams, Alfie Abbott, Matthew Adam, Basir Abdul, Nabeel Abdallah, Rasheed Abdul-Raheem, Mustafa Abbas, Niyaz Abdulshukkoor, Kula Abdusamad, Akata Abung, Catherine Acton, Carol Adams, Bushra Abdelqader, Yaa Aceampong, Miriam Abraham, Hani Abo-Leyah(University of Dundee), Huzaifa Adamali, Syed M Abubacker, Ashraf Omar Abdelaziz(Ain Shams University), Andrés Acosta(Mayo Clinic), Adebanke Aboaba, Ahmad Abu-Arafeh, Fatima Abbas, Katrina Abernethy, Mohamed A. O. Abdelfattah, Abeer Ul-Amna, Abdulfatahi Abdulmumeen, Hyacinth-John Abu(University of Dundee), Rezan A. Kadir(The Royal Free Hospital), Abdullah Abdullah(University of Malakand), Ali Abbas(University of Dundee), Fiona Adam, Devikumar Acharya, Hakam Abbass, Abdulakeem Ajibode, Tizzy Abraham, Mai Abedalla
Cited by 384
Related Papers
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
|The Lancet|2021|564
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
|The Lancet|2021|523
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
|The Lancet|2022|329